New drug aims to help people quit opioids without using more opioids

NCT ID NCT06384157

Completed Disease control Sponsor: Indivior Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This study tested a new medication called INDV-2000 in 300 adults with moderate to severe opioid use disorder who had recently started or completed withdrawal treatment. The goal was to see if INDV-2000 could help them stay opioid-free for 3 months without needing another opioid medication. Participants received either INDV-2000 or a placebo, and researchers measured how many people avoided relapse or dropping out of the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Accel Research Sites - Lakeland

Lakeland, Florida, 33803, United States
Agile Clinical Research Trials

Atlanta, Georgia, 30328, United States
Alpine Research Organisation

Clinton, Utah, 84015, United States
Arch Clinical Trials

St Louis, Missouri, 63141, United States
Artemis Institute For Clinical Research - San Diego

San Diego, California, 92103, United States
Boeson Clinical Research

Provo, Utah, 84604, United States
Bold City Clinical Research

Jacksonville, Florida, 32224, United States
Boyett Health Services Inc

Hamilton, Alabama, 35570, United States
Clinical Research Center of Florida

Pompano Beach, Florida, 33060, United States
Dr Vando Medical Services

The Bronx, New York, 10464, United States
El Paso Clinical Trials

El Paso, Texas, 79902, United States
Elite Clinical Studies, LLC

Phoenix, Arizona, 85018, United States
Empire Clinical Research

Pomona, California, 91767, United States
HD Research

Houston, Texas, 77043, United States
IMA Clinical Research

Las Vegas, Nevada, 89102, United States
Imagine Research of Palm Beach County

Boynton Beach, Florida, 33435, United States
Insight Research Institute

Flint, Michigan, 48507, United States
Insite Clinical Research, LLC

DeSoto, Texas, 75115, United States
Maryland Treatment Centers

Baltimore, Maryland, 21229, United States
Midwest Clinical Research Center, LLC

Dayton, Ohio, 45417, United States
Monroe Biomedical Research

Monroe, North Carolina, 28112, United States
North County Clinical Research

Oceanside, California, 92054, United States
Oasis Clinical Research

Las Vegas, Nevada, 89121, United States
Pahl Pharmaceutical Professionals, LLC

Oklahoma City, Oklahoma, 73112, United States
Precise Research Centers

Flowood, Mississippi, 39232, United States
Prisma Health Addiction Medicine Center

Greenville, South Carolina, 29605, United States
Progressive Clinical Research Llc

Bountiful, Utah, 84010, United States
Quantum Clinical Trials

Miami Beach, Florida, 33140, United States
Richmond Behavioral Associates

Staten Island, New York, 10314, United States
SP Research PLLC Rivus Wellness and Research Insitute

Oklahoma City, Oklahoma, 73112, United States
Segal Trials Miami Lakes

Miami Lakes, Florida, 33016, United States
Unity Clinical Research

Oklahoma City, Oklahoma, 73118, United States
Vitalix Clinical

Worcester, Massachusetts, 01608, United States
Vitalix Kissimmee

Kissimmee, Florida, 34741, United States
West Clinical Research

Morehead City, North Carolina, 28557, United States

Conditions

Explore the condition pages connected to this study.

OPIOID USE DISORDER